logo
15:43 Dec 05

Pfizer Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
5000.00
-1.00 (-0.02%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Pfizer Ltd. Financials

Pfizer Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
5000.00
-1.00 (-0.02%)
15:43 Dec 05
Quality
image/svg+xml

79/100
High Financial Strength

Valuation
image/svg+xml

37/100
Mid Valuation

Technical

46/100
Technically Neutral

Strength

9

Weakness

4

Opportunity

1

Threats

0

33.24 %

ROE %

27.21 %

ROA %

183.46

EPS

301.94

BVPS

40.85 %

Net Profit Margin

Nov 2006 Nov 2007 Nov 2008
Net Sales
733.7 735.6 733.2
Operating Expenses +
568.02 579.1 580.77
Raw Material
246.68 238.95 271.31
Increase Decrease in Cost
-10.25 4.77 -22.49
Other Manufacturing Expense
26.8 29.05 30.99
Employee Cost
102.34 101.7 102.1
Miscellaneous Expenses
417.35 383.81 348.78
Operating Profit
165.68 156.5 152.43
Other Income
33.47 319.87 66.02
Depreciation
13.07 9.58 11.12
Interest
0.07 0.02 0
Profit before tax and exceptio..
186.01 466.76 207.33
Exceptional Items
0 0 0
PBT
186.01 466.76 207.33
Provision for Taxation
56.31 111.34 119.56
Net Profit
106.33 340 299.57
NET Profit after MI
106.33 340 299.57
EPS
35.63 113.93 100.38
Operating Profit Margin (%)
22.58 21.28 20.79
Net Profit Margin (%)
14.49 46.22 40.86

Pfizer Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 63.90 63.90 63.90 63.90 63.90 63.90
FII 2.60 2.40 2.20 2.70 3.50 3.20
Public 17.10 17.20 17.10 16.80 16.10 15.80
Others 16.40 16.50 16.80 16.60 16.50 17.10
Shareholder Shares Holding %
Research 360 logo
Download Our App On: